These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8553730)

  • 1. [The use of a cell immobilization technic for the continuous cultivation of toxin-forming anaerobes].
    Telishevskaia LIa
    Zh Mikrobiol Epidemiol Immunobiol; 1995; (6):21-2. PubMed ID: 8553730
    [No Abstract]   [Full Text] [Related]  

  • 2. [Biological-economic study of the Clostridium perfringens cultivation processes. 1. Value of the phasic portrait in the prognosis of the processes of microbial cultivation].
    Basnak'ian IA; Zaporozhtsev LN; Gruntovich VS; Mel'nikova VA; Krylov IuM
    Zh Mikrobiol Epidemiol Immunobiol; 1977 Sep; (9):12-6. PubMed ID: 202118
    [No Abstract]   [Full Text] [Related]  

  • 3. [Analysis and improvement of culture processes of pathogenic microorganisms].
    Zaporozhtsev LN
    Zh Mikrobiol Epidemiol Immunobiol; 1981; (8):19-25. PubMed ID: 6274109
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of an experimental analytical method for equilibrating nutrient broths for Clostridium perfringens type A growth and toxin formation].
    Artemenko VD; Ivanova LG; Nenashev VP; Kuznetsova GI; Ochkina NI
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Nov; (11):37-41. PubMed ID: 2868592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of molasses and whey in culture media for the development and production of a toxin from Clostridium perfringens type D].
    Silva HJ; Giulietti AM; Segovia RF; Ertola RJ
    Rev Argent Microbiol; 1982; 14(2):85-90. PubMed ID: 6101000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medium for toxin production by Clostridium perfringens in continuous culture.
    Chou G
    Appl Microbiol; 1971 May; 21(5):794-8. PubMed ID: 4324884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of iron on the growth and toxin formation of Clostridium perfringens type A cultures].
    Artemenko VD; Kuznetsova GI; Nenashev VP
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Oct; (10):20-4. PubMed ID: 6098107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Biologic-economic study of processes for cultivating Clostridium perfringens. II. Comparison of the effectiveness of actual and predicted processes for cultivating microorganisms].
    Zaporozhtsev LN; Basnak'ian IA; Il'nitskaia EA; Vlasenko AP; Artem'eva TA
    Zh Mikrobiol Epidemiol Immunobiol; 1977 Oct; (10):37-43. PubMed ID: 200039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Production of a vaccine against enterotoxemia from Clostridium perfringens strains isolated in the field].
    Cherfaoui S; Kadra B
    Arch Inst Pasteur Alger; 1992; 58():205-24. PubMed ID: 1309137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth conditions of clostridium perfringens type B for production of toxins used to obtain veterinary vaccines.
    Viana Brandi I; Domenici Mozzer O; Jorge EV; Vieira Passos FJ; Lopes Passos FM; Cangussu AS; Macedo Sobrinho E
    Bioprocess Biosyst Eng; 2014 Sep; 37(9):1737-42. PubMed ID: 24573216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification of alpha toxin from Clostridium perfringens: phospholipase C.
    Jolivet-Reynaud C; Moreau H; Alouf JE
    Methods Enzymol; 1988; 165():91-4. PubMed ID: 2906730
    [No Abstract]   [Full Text] [Related]  

  • 12. The influence of carbon dioxide on the growth of obligate and facultative anaerobes on solid media.
    Watt B
    J Med Microbiol; 1973 Aug; 6(3):307-14. PubMed ID: 4353643
    [No Abstract]   [Full Text] [Related]  

  • 13. The effects of probiotic Bacillus coagulans on the cytotoxicity and expression of alpha toxin gene of Clostridium perfringens type A.
    Kawarizadeh A; Tabatabaei M; Hosseinzadeh S; Farzaneh M; Pourmontaseri M
    Anaerobe; 2019 Oct; 59():61-67. PubMed ID: 31125604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemically defined medium for the growth of Clostridium perfringens.
    Riha WE; Solberg M
    Appl Microbiol; 1971 Oct; 22(4):738-9. PubMed ID: 4331776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A method for preparing a pre-reduced, chemically defined, filter sterilized medium for growing Clostridium perfringens.
    Ades GL; Pierson MD
    J Appl Bacteriol; 1973 Dec; 36(4):739-41. PubMed ID: 4362617
    [No Abstract]   [Full Text] [Related]  

  • 16. [alpha-toxin (phospholipase C) of Clostridium perfringens (author's transl)].
    Ohsaka A
    Tanpakushitsu Kakusan Koso; 1976 Nov; Suppl():121-44. PubMed ID: 194279
    [No Abstract]   [Full Text] [Related]  

  • 17. Production and properties of theta-toxin of Clostridium perfringens with special reference to lethal activity.
    Soda S; Ito A; Yamamoto A
    Jpn J Med Sci Biol; 1976 Dec; 29(6):335-49. PubMed ID: 192930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New presumptive identification test for Clostridium perfringens: reverse CAMP test.
    Hansen MV; Elliott LP
    J Clin Microbiol; 1980 Oct; 12(4):617-9. PubMed ID: 6252247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brachyspira (Serpulina) pilosicoli of human origin interfere with the growth of Clostridium perfringens alpha-toxin producer.
    Calderaro A; Dettori G; Ragni P; Guégan R; Arcangeletti MC; Medici MC; Chezzi C
    New Microbiol; 2002 Apr; 25(2):139-47. PubMed ID: 12019719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced production of phospholipase C and perfringolysin O (alpha and theta toxins) in a gatifloxacin-resistant strain of Clostridium perfringens.
    Rafii F; Park M; Bryant AE; Johnson SJ; Wagner RD
    Antimicrob Agents Chemother; 2008 Mar; 52(3):895-900. PubMed ID: 18160514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.